Terry Pearson
Technik-/Wissenschafts-/F&E-Leiter bei Siscapa Assay Technologies, Inc.
Aktive Positionen von Terry Pearson
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Science Council of British Columbia | Direktor/Vorstandsmitglied | 01.09.2010 | - |
CAVA Healthcare, Inc.
CAVA Healthcare, Inc. Food: Specialty/CandyConsumer Non-Durables CAVA Healthcare, Inc. operates as a early stage biotechnology company. The company is headquartered in Surrey, Canada. | Direktor/Vorstandsmitglied | - | - |
Siscapa Assay Technologies, Inc.
Siscapa Assay Technologies, Inc. BiotechnologyHealth Technology Siscapa Assay Technologies, Inc. provides products and services for precise quantitation of protein biomarkers, drugs, and drug targets using immuno-affinity mass spectrometry. Siscapa assays are used in clinical diagnostics and pharma R&D for particularly demanding applications, and in biomarker panels to characterize changes in health, disease, and treatment in longitudinal user-collected dried blood microsamples. Siscapa immuno-affinity mass spectrometry assays for targeted protein quantitation can be developed more quickly than typical ELISA immunoassays since they require only a single specific antibody and provide absolute target specificity because of the MS detection. Because Siscapa assays do not interact with one another, these assays can be freely assembled in panels for various applications. The American company was founded by N. Leigh Anderson, who has been the CEO since incorporation. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Eyam Vaccines & Immunotherapeutics Ltd. | Direktor/Vorstandsmitglied | 10.01.2022 | - |
Karriereverlauf von Terry Pearson
Ehemalige bekannte Positionen von Terry Pearson
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BIOASIS TECHNOLOGIES INC. | Direktor/Vorstandsmitglied | 27.03.2008 | 21.09.2017 |
Independent Dir/Board Member | 27.03.2008 | 21.09.2017 | |
MARKER THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | - | 05.12.2005 |
University of British Columbia | Corporate Officer/Principal | - | - |
NEVIS BRANDS INC. | Direktor/Vorstandsmitglied | 16.12.2014 | - |
Independent Dir/Board Member | 16.12.2014 | - | |
University of Victoria | Corporate Officer/Principal | 01.01.1979 | - |
░░░ ░░░░░ ░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Ausbildung von Terry Pearson
University of British Columbia | Doctorate Degree |
Statistik
International
Kanada | 7 |
Vereinigte Staaten | 5 |
Operativ
Director/Board Member | 7 |
Independent Dir/Board Member | 2 |
Corporate Officer/Principal | 2 |
Sektoral
Health Technology | 5 |
Consumer Services | 3 |
Consumer Non-Durables | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
MARKER THERAPEUTICS, INC. | Health Technology |
BIOASIS TECHNOLOGIES INC. | Health Technology |
NEVIS BRANDS INC. | Health Technology |
Private Unternehmen | 5 |
---|---|
Siscapa Assay Technologies, Inc.
Siscapa Assay Technologies, Inc. BiotechnologyHealth Technology Siscapa Assay Technologies, Inc. provides products and services for precise quantitation of protein biomarkers, drugs, and drug targets using immuno-affinity mass spectrometry. Siscapa assays are used in clinical diagnostics and pharma R&D for particularly demanding applications, and in biomarker panels to characterize changes in health, disease, and treatment in longitudinal user-collected dried blood microsamples. Siscapa immuno-affinity mass spectrometry assays for targeted protein quantitation can be developed more quickly than typical ELISA immunoassays since they require only a single specific antibody and provide absolute target specificity because of the MS detection. Because Siscapa assays do not interact with one another, these assays can be freely assembled in panels for various applications. The American company was founded by N. Leigh Anderson, who has been the CEO since incorporation. | Health Technology |
CAVA Healthcare, Inc.
CAVA Healthcare, Inc. Food: Specialty/CandyConsumer Non-Durables CAVA Healthcare, Inc. operates as a early stage biotechnology company. The company is headquartered in Surrey, Canada. | Consumer Non-Durables |
The Terry Fox Foundation | |
Science Council of British Columbia | |
Eyam Vaccines & Immunotherapeutics Ltd. |
- Börse
- Insiders
- Terry Pearson
- Erfahrung